NeuroMetrix clears final FDA hurdle to market Sensus device

12/3/2012 | American City Business Journals

The FDA has cleared NeuroMetrix to market a disposable electrode that works with the firm's Sensus pain management device, which received clearance from the agency in August. The Sensus system employs electromagnetic nerve stimulation to treat leg pain in patients with diabetic peripheral neuropathy and is targeted for release before the end of 2012.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY